As we all know, electronic cigarettes or e-cigs are one of, if not the fast-growing segments of the nicotine products market. This summer, lawmakers in North Carolina will be debating two E-cigarette related proposals in their state house, and although “technically” there are two debates, both of these debates have relatively the same outcome; to raise much-needed state tax revenue.

I am not aware of any other federal law or regulation that prohibits companies from telling consumers the truth about their products as it relates to the primary benefit of the product. Hopefully, the FDA will see the error in its proposal and will reconsider its decision to subject electronic cigarettes to the provisions of section 911.

Dr. Benowitz: "Dr. Benowitz, as a paid consultant for pharmaceutical companies, has assisted them with the design, development, and marketing of smoking-cessation products. Among the companies for which he has consulted on such products are GlaxoSmithKline plc and its affiliates (collectively, “GSK”); Pfizer, Inc. and its affiliates (collectively, “Pfizer”); Novartis AG and its affiliates (collectively, “Novartis”); Sanofi-Aventis U.S. LLC and its affiliates (collectively, “Sanofi-Aventis”); and Aradigm Corp. and its affiliates (collectively, “Aradigm”). During the last ten years, he has received at least approximately $10,000 per year for such consulting. He has also received grant support for research and writing from GSK and/or Pfizer on at least five occasions. In 2010, he co-authored a study, funded by Pfizer, on the use of its drug, Chantix, for smoking cessation."

LAST：buy e cigarette your best choice super thinner pcc with automatic battery BW-enj PCC 2014 newest ecig |NEXT：2014 new best mechanical mod of 18350/18650 colorful chiyou mod